about
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and post...
Read More
121.32
9.35
(8.35%)
1.6M
XNAS Volume
XNAS 05 May, 2026 5:30 PM (EDT)
Not Eligible
Mid Valuation
Technically Neutral
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..